Codes / ICD10CM / E10.3393

E10.3393 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition where the pancreas produces little or no insulin. Moderate nonproliferative diabetic retinopathy is a complication affecting the retina, characterized by damage to retinal blood vessels without abnormal new blood vessel growth. This stage involves microaneurysms, retinal hemorrhages, and hard exudates. The absence of macular edema means the central retina remains free of swelling, though vision may still be impacted if the condition progresses. The bilateral specification indicates the condition affects both eyes.

Causes

Type 1 diabetes results from an autoimmune reaction that destroys insulin-producing cells in the pancreas. Diabetic retinopathy develops due to prolonged high blood sugar levels, which damage retinal blood vessels over time. The exact mechanisms include oxidative stress, inflammation, and vascular changes specific to ocular tissues. Moderate nonproliferative changes occur as the disease advances, while the lack of macular edema indicates the macula has not yet accumulated fluid. Bilateral involvement reflects symmetric disease progression in both eyes.

Risk Factors

  • Poor blood sugar control
  • Longer duration of diabetes
  • High blood pressure
  • High cholesterol levels
  • Smoking

Symptoms

  • Blurred or distorted vision
  • Floaters or spots in the visual field
  • Difficulty seeing fine details
  • Reduced night vision

Diagnosis

Diagnosis involves a comprehensive eye exam, including dilated retinal examination and imaging (e.g., optical coherence tomography or fluorescein angiography) to assess retinal changes. Blood tests to evaluate glycemic control and other metabolic markers may also be performed. The bilateral nature of the condition is confirmed by examining both eyes.

Treatment Options

  • Intensive blood sugar management to slow retinopathy progression
  • Blood pressure and cholesterol control
  • Regular eye exams to monitor for changes
  • Laser therapy or anti-VEGF injections if retinopathy advances
  • Lifestyle modifications (e.g., diet, exercise, smoking cessation)

Prognosis and Follow-Up

With proper management, progression to severe retinopathy can be slowed. Regular follow-up is critical to detect worsening changes early. Bilateral involvement requires ongoing monitoring of both eyes to prevent vision loss.

Complications

  • Progression to proliferative diabetic retinopathy
  • Macular edema (if fluid accumulates in the macula)
  • Vision impairment or blindness if untreated
  • Increased risk of other diabetic complications (e.g., nephropathy, neuropathy)

Lifestyle & Prevention

  • Maintain tight glycemic control through insulin therapy and monitoring
  • Manage blood pressure and cholesterol levels
  • Adopt a healthy diet and exercise routine
  • Avoid smoking and limit alcohol intake
  • Protect eyes from UV exposure and injury

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or eye pain. Regular eye exams are essential for early detection of retinopathy progression.

Tips for Medical Coders

Document the bilateral nature of the retinopathy and confirm the absence of macular edema. Ensure clinical notes specify both eyes are affected to support the code E10.3393. Include details on retinal findings (e.g., microaneurysms, hemorrhages) and glycemic control status for accurate coding.

Book a walkthrough

E10.3393 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.